MAPK3 and glioblastoma: It enhances the inactivation state of extracellular signal‐regulated kinase 1/2 (ERK1/2), downregulates the expression of the canonical mitogen‐activated protein kinase (MAPK)/ERK signaling pathway, and plays a pivotal role in the treatment of GBM.